Search - tctmd.com

Displaying 61 - 80 of 81

Sort: Relevancy | Date

Presentation

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter AVR

Presenter: Himanshu J. Patel

April 29, 2015

Presentation TCT 2014

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

Presenter: Kishore J. Harjai, Susheel Kodali

September 14, 2014

Presentation TVT 2014

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Michael J. Mack

June 07, 2014

Presentation

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Presenter: P. G?n?reux

December 02, 2013

Presentation

Trans-Catheter Closure of PDA by NitOcclud Coil - Trans-Aortic & Trans-Pulmonary Approach

Presenter: Avraham Lorber

December 02, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Presenter: Daniel Blackman

October 30, 2013

Presentation TCT 2013

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Presenter: Charles Davidson

October 30, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Presentation TCT 2013

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Presenter: Philippe Généreux

October 28, 2013

Presentation TCT 2013

Incidence, Predictors, and Outcomes of Strokes After Surgical AVR and TAVR

Presenter: D. Craig Miller

October 28, 2013

Presentation TCT 2013

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

Presenter: Neil Moat

October 27, 2013

Presentation TCT 2013

My Crystal Ball: The Future of Surgical AVR in the Era of TAVR

Presenter: Craig Smith

October 27, 2013

Presentation TCT 2013

Another “LIVE” Multi-Disciplinary Heart Team Case Presentation – High Risk Surgery or AVR

Presenter: Azeem Latib

October 27, 2013

Presentation SOLACI 2013

T-AVR (TAVI) Global Results.

Presenter: A. Pichard

July 24, 2013

Presentation TVT 2013

Cost-effectiveness of Surgical AVR vs. TAVR Using Registry Data

Presenter: Christopher Meduri

June 13, 2013

Presentation TCTAP 2013

Surgical AVR Remains the Procedure of Choice for Most AS Patients

Presenter: David P. Taggart

April 24, 2013

Presentation TCT 2012

Complex Thrombus Management

Presenter: Panayiotis Avraamides

October 25, 2012

Presentation TCT Mediterranean 2012

Thrombectomy in PPCI for STEMI: how to choose?

Presenter: Panayiotis Avraamides

May 04, 2012

Presentation

Short- and Mid-term Outcomes in Pts Undergoing TAVR vs. Minimally-Invasive or Full-Sternotomy AVR

Presenter: Vinod H. Thourani

February 01, 2012

Presentation

Resultados a Corto y Medio Plazo en Pacientes sometidos a TAVR frente a AVR mediante Cirugía Mínimamente Invasiva o Esternotomía Completa

Presenter: V. H. Thourani

February 01, 2012

Advertisement

Use of Psoas Muscle Size as a Frailty Assessment Tool for Open and Transcatheter AVR

Position Statement: TAVR Will Replace Surgical AVR in Low- and Intermediate-Risk Patients: Cath Labs Get Ready!

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

PARTNER: Bleeding Complications After Surgical AVR Compared with TAVR

Trans-Catheter Closure of PDA by NitOcclud Coil - Trans-Aortic & Trans-Pulmonary Approach

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - For: The Data are Clear (And Common Sense Rules): TAVR is a Lower Risk Option than...

Motion: The Envelope for TAVR Should be Expanded to All Candidates for Conventional AVR - Against: The TAVR Data are Only on High-Risk Patients with Limited Follow-Up

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Incidence, Predictors, and Outcomes of Strokes After Surgical AVR and TAVR

Which High-Risk AS Patients Should be Treated with TAVR and Which are Better Suited for Surgical AVR

My Crystal Ball: The Future of Surgical AVR in the Era of TAVR

Another “LIVE” Multi-Disciplinary Heart Team Case Presentation – High Risk Surgery or AVR

T-AVR (TAVI) Global Results.

Cost-effectiveness of Surgical AVR vs. TAVR Using Registry Data

Surgical AVR Remains the Procedure of Choice for Most AS Patients

Complex Thrombus Management

Thrombectomy in PPCI for STEMI: how to choose?

Short- and Mid-term Outcomes in Pts Undergoing TAVR vs. Minimally-Invasive or Full-Sternotomy AVR

Resultados a Corto y Medio Plazo en Pacientes sometidos a TAVR frente a AVR mediante Cirugía Mínimamente Invasiva o Esternotomía Completa

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content